While representing HyphenSCS at the MassChallenge Israel, Arun Pandit met Cuspa CEO Ariel Weigler.
One in eight people over 75 has valvular heart disease (VHD).
An innovative and economical artificial cusp made by Cuspa is intended to close the regurgitant orifice in cases of valve insufficiency while preserving normal valve function.
The Cusper device provides a minimally invasive option for treating valve insufficiency, focusing on aortic insufficiency in a straightforward, intuitive procedure that is anticipated to benefit a patient population with few other options.
Best wishes!